Thomas Kegel - Concepedia

Author

Thomas Kegel

Martin Luther University Halle-Wittenberg

Also Known As

R Grosse, T Kegel, T. Kegel, Thomas Kegel, Thomas M. Kegel

Publications

672

Citations

H-Index

Concepts

All Affiliations

Martin Luther University Halle-Wittenberg Luther University University Hospital in Halle University Medical Center Hamburg-Eppendorf Mayo Clinic in Arizona

About

Thomas Kegel is an author at Martin Luther University Halle-Wittenberg specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	221
2	Pathology	3	3	98
3	Health Sciences	2	2	32
4	Immunology	1	1	34
5	Orthopaedics	1	1	65

Thomas Kegel

Publications

413

Citations

H-Index

Page 1

	Year	Citations
The hand-foot syndrome--a frequent secondary manifestation in antineoplastic chemotherapy. Matthias Janusch, Michael A. Fischer, W. C. Marsch, PubMed Sub-basal EdemaSurgical OncologyPathologyDermatologyCancer Chemotherapy	2007	65
Successful treatment of mediastinal lymphomatoid granulomatosis with rituximab monotherapy Karin Jordan, Axel Grothey, Wilfried Grothe, European Journal Of Haematology	2005	57
Desmoplastic small round cell tumors: Multimodality treatment and new risk factors Monika Scheer, Christian Vokuhl, Bernd Blank, Cancer Medicine	2019	57
Potential activity of paclitaxel, vinorelbine and gemcitabine in anaplastic thyroid carcinoma Wieland Voigt, Thomas Kegel, Thomas Mueller, Journal of Cancer Research and Clinical Oncology Potential ActivityTumor BiologyAnaplastic Thyroid CarcinomaOncologyMedicine	2005	41
Phase II Trial of Capecitabine/Irinotecan and Capecitabine/Oxaliplatin in Advanced Gastrointestinal Cancers Karin Jordan, O Kellner, Thomas Kegel, Clinical Colorectal Cancer Phase Ii TrialGastrointestinal OncologyMedicinePharmacologyAdvanced Gastrointestinal Cancers	2004	36
The NK-1 receptor-antagonist aprepitant in high-dose chemotherapy (highdose melphalan and high-dose T-ICE: paclitaxel, ifosfamide, carboplatin, etoposide): efficacy and safety of a triple antiemetic combination Karin Jordan, Franziska Jahn, Patrick Jahn, Bone Marrow Transplantation Highdose MelphalanOncologyMedicineImmunologyImmune Checkpoint Inhibitor	2010	34
A New Chemoembolization Protocol in Refractory Liver Metastasis of Colorectal Cancer – a Feasibility Study Wieland Voigt, Curd Behrmann, Annette J. Schlueter, Oncology Research and Treatment	2002	29
Chemotherapy with Paclitaxel and Gemcitabine in Progressive Medullary and Thyroid Carcinoma of the Follicular Epithelium A. Matuszczyk, Stephan Petersenn, Wieland Voigt, Hormone and Metabolic Research PathologyMetronomic ChemotherapyTumor BiologyOncologyMean Age 53	2009	20
Treatment of Adolescents and Young Adults (AYA) with Cancer in a Multidisciplinary Setting: On the Way to a Highly Specialized AYA Unit Toralf Bernig, Franziska Jahn, S. Witkowsky, Klinische Pädiatrie	2013	15
Phase 2 Trial of Docetaxel, Gemcitabine, and Oxaliplatin Combination Chemotherapy in Platinum- and Paclitaxel-Pretreated Epithelial Ovarian Cancer G Seliger, Lutz Peter Mueller, Thomas Kegel, International Journal of Gynecological Cancer	2009	14

Page 1